The SMAC mimetic, LCL-161, reduces survival in aggressive MYC-driven lymphoma while promoting susceptibility to endotoxic shock.

West, A C

The SMAC mimetic, LCL-161, reduces survival in aggressive MYC-driven lymphoma while promoting susceptibility to endotoxic shock. [electronic resource] - Oncogenesis Apr 2016 - e216 p. digital

Publication Type: Journal Article

2157-9024

10.1038/oncsis.2016.26 doi